Clinical efficacy of transcranial ultrasound thrombolysis combined with atorvastatin calcium in the treatment of atherosclerotic cerebral infarction
Objective To study and analyze the clinical effect of transcranial ultrasound thrombolysis combined with atorvastatin calcium in the treatment of atherosclerotic cerebral infarction. Methods Selected 120 patients with atherosclerotic cerebral infarction during January 2014 to September 2017 treated in Luochuan County Hospital were divided into control group and experimental group, 60 cases in each group. The two groups were treated with routine treatment, and the control group was given atorvastatin calcium, 20 mg per day, oral. The experimental group received transcranial ultrasound thrombolysis on the basis of control group, 2 times per day, once for 20 minutes. The clinical indicators such as high-density lipoprotein cholesterol, total cholesterol and carotid plaque index were compared and analyzed in the experimental group and the control group. Results After treatment, the IMT in the experimental group was (1.01±0.32) mm significantly smaller than that in the control group (1.42±0.52) mm (P<0.05). After treatment, the score of NIHSS in the experimental group was (7.32±1.67), and the score of NIHSS in the control group was (10.32±1.68), with statistical difference (P<0.05). After treatment, the experimental group HDL-C level (2.14±0.23) mmol/L, significantly higher than the control group (1.98±0.20) mmol/L. In addition, the average level of total cholesterol, triglyceride and LDL-C in the experimental group was better than the control group (P<0.05). Conclusion Transcranial ultrasound thrombolysis combined with atorvastatin calcium in the treatment of atherosclerotic cerebral infarction clinical effect is ideal,can significantly improve the lipid level of patients, help patients recover, alleviate atherosclerosis.
NETL
NSTL
万方数据
维普
